Patents by Inventor Nuria DE PEDRO MONTEJO

Nuria DE PEDRO MONTEJO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR MEASURING TELOMERE ASSOCIATED VARIABLES AND USES THEREOF FOR THE DIAGNOSIS AND/OR PROGNOSIS OF TELOMERIC-ASSOCIATED DISEASES
    Publication number: 20220106635
    Abstract: The invention provided methods in vitro for diagnosis and/or prognosis of a clinical outcome in a subject with a telomere-associated disease comprising determining specific telomere associated variables (TAVs) of a test sample cell from the subject, wherein the value of the TAVs obtained for the test sample compared to a control sample is indicative of the telomerase-associated disease and/or the clinical outcome of the subject.
    Type: Application
    Filed: December 24, 2019
    Publication date: April 7, 2022
    Inventors: Maria Pilar NAJARRO PARRA, Luis FERNANDEZ CANIVELL, Laura ESTEBAN LA FUENTE, Nuria DE PEDRO MONTEJO, Maria DIEZ ZAERA, Jorge GARCIA MARTINEZ
  • Phenol derivatives to treat cancer
    Patent number: 10414745
    Abstract: The present invention relates to compounds of general formula (I) wherein R1-R8 take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of cancer.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: September 17, 2019
    Assignee: FUNDACIÓN MEDINA. CENTRO DE EXCELENCIA EN INVESTIGACIÓN DE MEDICAMENTOS INNOVADORES EN ANDALUCÍA
    Inventors: Nuria De Pedro Montejo, Victor Gonzalez Menendez, Gloria Crespo Sueiro, Ignacio Perez-Victoria Moreno De Barreda, Bastien Cautain, Maria Francisca Vicente Perez, Jose Fernando Reyes Benitez, Olga Genilloud Rodriguez, Carmen Grinan Lison, Juan Antonio Marchal Corrales
  • PHENOL DERIVATIVES TO TREAT CANCER
    Publication number: 20180148427
    Abstract: The present invention relates to compounds of general formula (I) wherein R1-R8 take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of cancer.
    Type: Application
    Filed: April 29, 2016
    Publication date: May 31, 2018
    Applicant: FUNDACION MEDINA CENTRO DE EXCELENCIA DE MEDICAMENTOS INNOVA
    Inventors: Nuria DE PEDRO MONTEJO, Victor GONZALEZ MENENDEZ, Gloria CRESPO SUEIRO, Ignacio PEREZ-VICTORIA MORENO DE BARREDA, Bastien CAUTAIN, Maria Francisca VICENTE PEREZ, Jose Fernando REYES BENITEZ, Olga GENILLOUD RODRIGUEZ, Carmen GRINAN LISON, Juan Antonio MARCHAL CORRALES